(Q42450370)

31 October 2017

Hydrocortisone alone vs hydrocortisone plus aminoglutethimide: a comparison of the endocrine effects in postmenopausal breast cancer (English)

1 reference

31 October 2017

Hydrocortisone alone vs hydrocortisone plus aminogluthethimide: a comparison of the endocrine effects in postmenopausal breast cancer (English)

1 reference

https://api.crossref.org/works/10.1016/0277-5379(84)90230-X

3 September 2023

1 reference

1 reference

https://api.crossref.org/works/10.1016/0277-5379(84)90230-X

3 September 2023

author name string

A. L. Harris

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6233150

3 September 2023

M. Dowsett

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6233150

3 September 2023

I. E. Smith

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6233150

3 September 2023

S. Jeffcoate

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6233150

3 September 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6233150

3 September 2023

publication date

1 April 1984

1 reference

full work available at URL

31 October 2017

https://api.elsevier.com/content/article/PII:027753798490230X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0277-5379(84)90230-X

https://api.elsevier.com/content/article/PII:027753798490230X?httpAccept=text/plain

3 September 2023

1 reference

https://api.crossref.org/works/10.1016/0277-5379(84)90230-X

European Journal of Cancer & Clinical Oncology

3 September 2023

published in

1 reference

31 October 2017

20

1 reference

31 October 2017

4

1 reference

31 October 2017

463-469

1 reference

Aminoglutethimide in the treatment of advanced postmenopausal breast cancer

31 October 2017

1

1 reference

https://api.crossref.org/works/10.1016/0277-5379(84)90230-X

Aminoglutethimide (Elipten-Ciba) as an inhibitor of adrenal steroidogenesis: mechanism of action and therapeutic trial.

3 September 2023

2

1 reference

https://api.crossref.org/works/10.1016/0277-5379(84)90230-X

Source of Estrogen Production in Postmenopausal Women1

3 September 2023

4

1 reference

https://api.crossref.org/works/10.1016/0277-5379(84)90230-X

Aminoglutethimide Inhibits Extraglandular Estrogen Production in Postmenopausal Women with Breast Carcinoma*

3 September 2023

5

1 reference

https://api.crossref.org/works/10.1016/0277-5379(84)90230-X

THE EXCRETION OF OESTRONE, PREGNANEDIOL AND PREGNANETRIOL IN BREAST CANCER PATIENTS. II. EFFECT OF OVARIECTOMY, OVARIAN IRRADIATION AND CORTICOSTEROIDS

3 September 2023

6

1 reference

https://api.crossref.org/works/10.1016/0277-5379(84)90230-X

Hormonal treatment of disseminated cancer of the female breast

3 September 2023

8

1 reference

https://api.crossref.org/works/10.1016/0277-5379(84)90230-X

Cortisone-thyroid therapy of metastatic mammary cancer.

3 September 2023

9

1 reference

https://api.crossref.org/works/10.1016/0277-5379(84)90230-X

A randomized trial comparing surgical adrenalectomy with aminoglutethimide plus hydrocortisone in women with advanced breast cancer

3 September 2023

10

1 reference

https://api.crossref.org/works/10.1016/0277-5379(84)90230-X

A comparative evaluation of adrenalectomy and cortisone in the treatment of advanced mammary carcinoma

3 September 2023

11

1 reference

https://api.crossref.org/works/10.1016/0277-5379(84)90230-X

The use of hydrocortisone in cancer

3 September 2023

12

1 reference

https://api.crossref.org/works/10.1016/0277-5379(84)90230-X

Dexamethasone in advanced breast cancer

3 September 2023

13

1 reference

https://api.crossref.org/works/10.1016/0277-5379(84)90230-X

The use of prednisolone in the treatment of disseminated breast carcinoma

3 September 2023

14

1 reference

https://api.crossref.org/works/10.1016/0277-5379(84)90230-X

Endocrine and Therapeutic Effects of Aminoglutethimide in Premenopausal Patients with Breast Cancer

3 September 2023

17

1 reference

https://api.crossref.org/works/10.1016/0277-5379(84)90230-X

Aminoglutethimide dose and hormone suppression in advanced breast cancer

3 September 2023

18

1 reference

https://api.crossref.org/works/10.1016/0277-5379(84)90230-X

Endogenous oestradiol-17β concentration in breast tumours determined by mass fragmentography and by radioimmunoassay: Relationship to receptor content

3 September 2023

19

1 reference

https://api.crossref.org/works/10.1016/0277-5379(84)90230-X

Regulation of Aromatase Activity of Stromal Cells Derived from Human Adipose Tissue*

3 September 2023

20

1 reference

https://api.crossref.org/works/10.1016/0277-5379(84)90230-X

The Hormonal Activity of the Postmenopausal Ovary

3 September 2023

22

1 reference

https://api.crossref.org/works/10.1016/0277-5379(84)90230-X

Adrenal Suppression with Aminoglutethimide. III. Comparison of Plasma Δ4- and Δ5-Steroids in Postmenopausal Women Treated for Breast Carcinoma*

3 September 2023

23

1 reference

https://api.crossref.org/works/10.1016/0277-5379(84)90230-X

Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancer

3 September 2023

24

1 reference

https://api.crossref.org/works/10.1016/0277-5379(84)90230-X

Serum Aminoglutethimide Levels: Studies of Serum Half-Life, Clearance, and Patient Compliance

3 September 2023

26

1 reference

https://api.crossref.org/works/10.1016/0277-5379(84)90230-X

Steroid sex hormones and prolactin in postmenopausal women with generalized mammary carcinoma during prolonged dexamethasone treatment

3 September 2023

27

1 reference

https://api.crossref.org/works/10.1016/0277-5379(84)90230-X

3 September 2023

Identifiers

1 reference

31 October 2017

1 reference